UK markets close in 8 hours 7 minutes

Grifols, S.A. (GRF.MC)

MCE - MCE Delayed price. Currency in EUR
Add to watchlist
16.99+0.17 (+1.04%)
As of 09:08AM CET. Market open.
Full screen
Previous close16.82
Bid16.98 x 0
Ask16.98 x 0
Day's range16.82 - 16.99
52-week range15.08 - 26.07
Avg. volume1,106,665
Market cap10.118B
Beta (5Y monthly)0.19
PE ratio (TTM)17.53
EPS (TTM)0.97
Earnings date24 Feb 2022 - 28 Feb 2022
Forward dividend & yield0.36 (2.15%)
Ex-dividend date03 Jun 2021
1y target est25.40
  • Reuters

    Spain's Grifols to buy rival Biotest for up to $1.9 billion

    MADRID (Reuters) -Spanish pharmaceuticals company Grifols proposed a 1.6 billion euro ($1.9 billion) takeover of its German rival Biotest on Friday, in a move to consolidate the plasma-based drug industry. Grifols said it had agreed with Tiancheng International Investment to buy the Hong Kong-based company's controlling stake in Biotest for 1.1 billion euros. The Barcelona-based company agreed to buy 89.88% of Biotest's ordinary shares that carry voting rights, but which represent only 44.54% of the company's capital, and a further 0.54% of capital in preferred shares that do not carry voting rights, from Hong Kong-based Tiancheng.

  • Zacks

    Moving Average Crossover Alert: Grifols (GRFS)

    Grifols (GRFS) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

  • Zacks

    New Strong Sell Stocks for March 8th

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today